# US 2019/0317112 A1 · Blood analysis method and blood test kit

> Agents: this data is available as JSON from the patentgrep API and MCP server — see https://patentgrep.com/llms.txt

- Number: US 2019/0317112 A1
- Document ID: US20190317112A1
- Status: Published application
- Kind: A1
- Application number: 16/454,064
- Filed: 2019-06-27
- Published: 2019-10-17
- Earliest claimed: 2016-12-28
- Assignees: FUJIFILM Corporation
- Applicants: FUJIFILM Corporation
- Inventors: Kota FUKUI; Shinya SUGIMOTO; Isao YONEKUBO
- Web page: https://patentgrep.com/patent/US20190317112A1

## CPC

- G01N 33/48: Biological material, e.g. blood, urine (G01N33/02, G01N33/26, G01N33/44, G01N33/46 take precedence); Haemocytometers (counting blood corpuscules distributed over a surface by scanning the surface G06M11/02)
- G01N 33/721: {Haemoglobin}
- G01N 1/38: Diluting, dispersing or mixing samples
- G01N 33/491: {by separating the blood components (G01N15/05 takes precedence)}
- G01N 33/96: involving blood or serum control standard
- G01N: INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES (measuring or testing apparatus or processes other than immunoassay, involving enzymes or microorganisms C12M, C12Q)

## Abstract

An object of the present invention is to provide a blood analysis method and a blood test kit, which are capable of performing measurement of a plurality of target components to be analyzed with high accuracies in a case where hemolysis occurs in a case of measuring an amount of target components to be analyzed in a small volume of a blood sample. According to the present invention, provided is a blood analysis method for measuring a concentration of a target component to be analyzed, the blood analysis method including: a step of diluting a collected blood sample with a diluent solution, a step of determining a dilution factor by using a normal value of a normal component which is homeostatically present in blood, a step of analyzing the concentration of the target component to be analyzed in the blood sample, measuring an amount of hemolysis in the blood sample, correcting the dilution factor according to the measured amount of hemolysis, and analyzing the concentration of the target component to be analyzed using the corrected dilution factor.

## Claims

### Claim 1

A blood analysis method for measuring a concentration of a target component to be analyzed, the blood analysis method comprising:
a step of diluting a collected blood sample with a diluent solution;
a step of determining a dilution factor by using a normal value of a normal component which is homeostatically present in blood; and
a step of analyzing the concentration of the target component to be analyzed in the blood sample,
wherein the method performs
measuring an amount of hemolysis in the blood sample,
correcting the dilution factor according to the measured amount of hemolysis, and
analyzing the concentration of the target component to be analyzed using the corrected dilution factor.

### Claim 2 (depends on 1)

The blood analysis method according to claim 1, which is performed by using a blood test kit,
wherein the blood test kit includes
the diluent solution for diluting the blood sample,
separating means for recovering a blood plasma component from the diluted blood sample; and
a container for storing the blood plasma component recovered from the diluted blood sample.

### Claim 3 (depends on 2)

The blood analysis method according to claim 2,
wherein the diluent solution contains a normal component not present in blood, and
the blood test kit is for analyzing the concentration of the target component to be analyzed in the blood sample using the normal component not present in blood.

### Claim 4 (depends on 2)

The blood analysis method according to claim 2,
wherein the blood plasma component is recovered from the diluted blood sample by using the blood test kit,
a dilution factor of the diluted blood sample is determined using the normal component which is homeostatically present in the recovered blood plasma component, and
the concentration of the target component to be analyzed in the blood sample is analyzed.

### Claim 5 (depends on 2)

The blood analysis method according to claim 2,
wherein the diluent solution contains a normal component not present in blood, and
the blood test kit determines a dilution factor of the diluted blood sample using the normal component not present in blood, and analyzes the concentration of the target component to be analyzed in the blood sample.

### Claim 6 (depends on 1)

The blood analysis method according to claim 1, wherein the normal component homeostatically present in blood is at least one substance selected from sodium ions, chloride ions, potassium ions, magnesium ions, calcium ions, total proteins, or albumins.

### Claim 7 (depends on 1)

A blood test kit which is used in the blood analysis method according to claim 1, the blood test kit comprising:
a diluent solution for diluting a blood sample;
separating means for recovering a blood plasma component from the diluted blood sample; and
a container for storing the blood plasma component recovered from the diluted blood sample.
